Economic evaluation of [18F]fluorocholine PET/CT in pre operative assessment of hyperfunctional parathyroids in primary hyperparathyroidism: a cost effectiveness analysis
[<sup>18</sup>F]Fluorocholine PET/CT stand-alone could be a cost-effective option and considered as a first line imaging strategy. Imaging strategies should be adapted to local healthcare contexts, reimbursement models, and diagnostic performance to optimize cost-effectiveness and patient care.
Authors
- Sihame Chkair
- Adel Mamou (ORCID: https://orcid.org/0000-0002-1709-9233)
- Vincent Boudousq
- Yassine Mamou
- O. Gilly
- Laurent Maı̈moun (ORCID: https://orcid.org/0000-0002-1727-1048)
- Sean C. Sheppard (ORCID: https://orcid.org/0000-0001-6427-3102)
- B. Lallemant
- Pierre Olivier Kotzki
Institutions
- Inserm (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Institut de Recherche en Cancérologie de Montpellier (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- EJNMMI Reports
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1186/s41824-025-00244-w
- Citations
- 9
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 12.88